MEDVi, a telehealth platform serving more than 100,000 patients, today announced an expanded physician-led program ...

Novo Nordisk CEO Mike Doustdar said on Monday as many as 1.5 million patients in the U.S. may be using compounded versions of ...

When endocrinologist Dan Bessesen, MD, looked online and saw how easy it would be for him to purchase a weight loss drug from ...

CARRY RISK. WEIGHT WATCHERS SAYS IT WILL NOW OFFER ELIGIBLE MEMBERS COMPOUNDED SEMAGLUTIDE AS PART OF ITS HOLISTIC WEIGHT MANAGEMENT PROGRAM. WE ARE AT A CROSSROADS HERE WHERE WE HAVE MILLIONS OF ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Once opened, compounded semaglutide typically lasts 28 days in the fridge. Compounded semaglutide, which contains the same active ...

Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or side effect disclosures. These compounded drugs, unlike generics, are not ...

Competition in the GLP-1 market is intensifying as new players pour into the weight-loss drug landscape. Ro Co-Founder and CEO Zach Reitano tells Market Domination he is "rooting for the [GLP-1] ...

I first met Jane (not her real name, of course) on a Friday afternoon in our clinic. She was referred for further evaluation of her chest pain, which, in the context of her family history of ...

Novo Nordisk’s CEO told CNN he is “alarmed” by the risks compounded versions of semaglutide — the active ingredient in the company’s diabetes drug Ozempic and weight loss drug Wegovy — are posing to ...

Weight-loss treatments like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) have been life changing for many individuals seeking to manage their weight. However, shortages and high ...

The roughly two-year shortage of GLP-1s has officially come to an end. That means, after May 22, compounding pharmacies can no longer produce any copies of the popular diabetes and weight loss drugs, ...